| Element List |
Explanation |
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is |
Revenue: In the second quarter of 2025, Nahdi Medical Company reported total revenue of SAR 2,527.6 million, reflecting a 2.2% increase year-over-year, compared to SAR 2,472.7 million in the same quarter last year. The second quarter results follow a strong performance in the first quarter this year and a higher base in the similar quarter last year, impacted by a shift in seasonality (please refer to the attached press release for detailed analysis). |
| The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is |
Net Profit: The company reported a net profit of SAR 238.4 million in the second quarter of 2025, compared to SAR 247.7 million in the same quarter last year, lower by SAR 9.3 million, due to the following reasons: - Gross Profit: Gross profit increased by 3.2% or SAR 29.7 million year-over-year, reaching SAR 966.0 million compared to SAR 936.2 million in the same quarter last year. Moreover, gross margin improved to 38.2% from 37.9% in the same quarter last year, supported by a favorable shift in product mix in the retail business. - Operating Profit: The company’s operating profit reached SAR 260.6 million, lower by SAR 12.8 million, compared to SAR 273.4 million in the same quarter last year, mainly driven by the accelerated business expansions. Items below operating profit reflected a net increase in expenses of SAR 3.4 million. As a result of the above, the company reported a 3.8% decline in the net profit. |
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is |
Revenue: The company recorded a total revenue of SAR 2,527.6 in the second quarter of 2025 representing a 4.1% decline compared to the previous quarter. This result reflects the expected normalization following the strong performance in the previous quarter of the current year, which benefited from the seasonality uplift. |
| The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is |
Net Profit: The company reported a net profit of SAR 238.4 million in the second quarter of 2025, lower by 6.6% or SAR 16.8 million. |
| The reason of the increase (decrease) in the sales/ revenues during the current period compared to the same period of the last year is |
Revenue: For the first half of 2025, Nahdi Medical Company recorded total revenue of SAR 5,162.5 million, reflecting a 9.1% year-over-year growth compared to SAR 4,730.2 in the same period last year. The Retail business remained the primary contributor to overall revenue growth, delivering a 7.3% increase, with solid performance across Pharma and Front Shop categories. The Healthcare and UAE businesses continued their accelerated growth during the period, delivering a year-over-year growth of 82.2% and 41.4% respectively. |
| The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year is |
Net Profit: The company reported a net profit of SAR 493.6 million in the first half of 2025, compared to SAR 480.7 million in the same period last year, reflecting a year-over-year growth of 2.7%, driven by the following reasons: - Gross Profit: Gross profit grew by 6.6% or SAR 118.2 million year-over-year, reaching SAR 1,909.8 million compared to SAR 1,791.6 million in the same period last year, supported by revenue growth. Gross margin stood at 37.0%, compared to 37.9% in the same period last year, mainly driven by the ongoing investments to support top-line growth and the accelerated growth in the Healthcare and online businesses, which operate not only with lower gross margins but also benefit from lower operating expenses. - Operating Profit: The company’s operating profit grew by 5.1%, supported by an increase in gross profit. During the period, the company accelerated new store openings while continuing to invest in the expansion of its Healthcare and UAE businesses, as well as in digital transformation initiatives. These investments led to higher operating expenses and affected the phasing of expenses throughout the period, impacting the profitability growth. However, this impact was partially offset by ongoing operational efficiency initiatives, which contributed to an improvement in operating expenses as a percentage of revenue by 0.4%, reaching 27.1%, compared to 27.5% in the same period last year. Consequently, operating profit reached SAR 530.6 million compared to SAR 505.1 million in the same period last year. Items below operating profit reflected a net increase in expenses of SAR 12.7 million, primarily to support revenue growth and accelerated business expansions. As result of the above factors, the company reported a 2.7% growth in the net profit |
| Statement of the type of external auditor's report |
Unmodified conclusion |
| Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) |
N/A |
| Reclassification of Comparison Items |
Certain comparative information has been reclassified to align with the current presentation for the period ending 30 Jun 2025. |
| Additional Information |
- Total Comprehensive Income decreased as a result of normal business activities which impacted on the actuarial estimate for the end-of-service indemnity. - In accordance with the company’s governance, it strictly adheres to Shariah principles in all areas of its business, including banking and investment activities. As a result, all costs incurred, and revenues generated from these activities are Shariah-compliant. |
| Attached Documents |
|
Comments